{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-045353","form_type":"8-K","ticker":"PVCT","cik":"0000315545","company_name":"PROVECTUS BIOPHARMACEUTICALS, INC.","filed_at":"2024-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.689327+00:00","generated_at":"2026-05-30T00:40:31.484235+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Provectus references Q4 2024 investor update; no specific details in filing","bullets":["Filing announces Fourth Quarter 2024 Investor Update presentation slides as Exhibit 99.1.","Presentation covers clinical, non-clinical, regulatory, manufacturing, and corporate development updates.","The exhibit content was not provided in this filing, so no concrete updates are available.","No financial or operational data disclosed; confidence in material news is low."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-045353","json":"https://secwatch.observer/filing/0001493152-24-045353.json","markdown":"https://secwatch.observer/filing/0001493152-24-045353.md","text":"https://secwatch.observer/filing/0001493152-24-045353.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/315545/000149315224045353/0001493152-24-045353-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/315545/000149315224045353/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T00:40:31.484235+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}